TCT-398 Impact of scaffold oversizing, underexpansion and postdilatation on acute angiographic and one year clinical outcomes in patients with ACS treated with bioresorbable vascular scaffolds. A pooled analysis from BVS STEMI First and BVS EXPAND studiesMariusz Tomaniak, Roberto Diletti, Cordula Felix et al.|Journal of the American College of Cardiology|2016Cited by 1
TCT-413 Feasibility of direct scaffolding in acute coronary syndromes patients with relatively simple non-calcified culprit lesions. A pooled analysis of BVS STEMI First and BVS Expand StudiesMariusz Tomaniak, Roberto Diletti, Jiang Ming Fam et al.|Journal of the American College of Cardiology|2016Cited by 0
TCT-440 Impact of optimal implantation technique on bioresorbable scaffold expansion and one-year clinical outcomes in patients presenting with acute coronary syndromes and calcified lesions. A pooled analysis of BVS STEMI First and BVS Expand StudiesMariusz Tomaniak, Roberto Diletti, Jiang Ming Fam et al.|Journal of the American College of Cardiology|2016Cited by 0
TCT-412 Long-term clinical outcomes after implantation of everolimus-eluting bioresorbable vascular scaffold in patients with acute myocardial infarction. 24-month clinical follow-up of the BVS STEMI First StudyMariusz Tomaniak, Roberto Diletti, Evelyn Regar et al.|Journal of the American College of Cardiology|2016Cited by 0
TCT-805 Angina frequency and quality of life after implantation of bioresorbable scaffold implantation in complex lesionsMariusz Tomaniak, Robert‐Jan van Geuns, Cordula Felix et al.|Journal of the American College of Cardiology|2017Cited by 0